linguistic:voice_change
Venom

Although venomous, eastern copperheads are generally not aggressive and bites are rarely fatal. Copperhead venom has an estimated lethal dose around 100 mg, and tests on mice show its potency is among the lowest of all pit vipers, and slightly weaker than that of its close relative, the cottonmouth. Copperheads often employ a "warning bite" when stepped on or agitated and inject a relatively small amount of venom, if any at all. "Dry bites" involving no venom are particularly common with the copperhead, though all pit vipers are capable of a dry bite. The fangs of dead pit vipers are capable of delivering venom in amounts that necessitate the use of antivenom.

Bite symptoms include extreme pain, tingling, throbbing, swelling, and severe nausea. Damage can occur to muscle and bone tissue, especially when the bite occurs in the outer extremities such as the hands and feet, areas in which a large muscle mass is not available to absorb the venom. A bite from any venomous snake should be taken very seriously and immediate medical attention sought, as an allergic reaction and secondary infection are always possible.

The venom of the southern copperhead has been found to hold a protein called "contortrostatin" that halts the growth of cancer cells in mice and also stops the migration of the tumors to other sites. However, this is an animal model, and further testing is required to verify safety and efficacy in humans.

The antivenom CroFab is used to treat copperhead envenomations that demonstrate localized or systemic reactions to the venom. As many copperhead bites can be dry (no envenomation), CroFab is not given in the absence of a reaction (such as swelling) due to the risk of complications of an allergic reaction to the treatment. The antivenom can cause an immune reaction called serum sickness. Pain management, tetanus immunization, laboratory evaluation, and medical supervision in the case of complications are additional courses of action. In 2002, an Illinois poison control center report on the availability of antivenom stated it used 1 Acp to 5 Acp depending on the symptoms and circumstances. Antivenom use however may not be necessary in the majority of cases, A study that analyzed 88 copperhead bite victims reported that all the victims survived and none required antivenom.